Prognosis, Treatment, and Prevention
2. New Auflage 2019,
608 Seiten, Kartoniert, Format (B × H): 216 mm x 279 mm, Gewicht: 1520 g
Verlag: Taylor & Francis Ltd
Pasqualini Breast CancerNow in its second edition, this bestselling title has been extensively revised and expanded to include new topics on:obesity and breast cancerinduction of anti-hormone and anti-growth factor resistance in breast cancerclinical implications of testosterone and breast cancerinsulin-like growth factorsdiscussions on the biological, genetic, and molecular pathways linked to the development and progression of breast canceranalyses on the latest therapeutic strategies, prognostic and predictive factors, and prevention strategiesExamining new developments, Breast Cancer: Prognosis, Treatment, and Prevention, Second Edition also covers:the mechanism involved in carcinogenesisthe relationship among a fetus, pregnancy, and breast cancerrecent developments in endocrine treatmentthe relationship among hormone replacement therapy, cytotoxic therapy, and other non-hormonal approaches for the treatment of metastasesmanagement of locally advanced breast cancer, and the importance of BRCA-1 and BRCA-2 in hereditary breast cancerWith new topics and updated chapters, this new edition keeps both oncologists and radiologists abreast of the current trends and advancements in the prognosis, treatment, and prevention of breast cancer.
Weitere Infos & Material
Breast Architecture and the Pathogenesis of Cancer. The Enzymatic Systems in the Formation and Transformation of Estrogens in Normal and Cancerous Human Breast. Control and Potential Clinical Applications. Pregnancy and Breast Cancer. The cellular origins of breast cancer subtypes. The Importance of Estrogen Receptors in Breast Cancer. Progesterone Receptor Isoforms and Human Breast Cancer. Compensatory signaling promoted by anti-hormones and anti-growth factor therapies in breast cancer: a starting point for the development of resistance to targeted treatments. Apoptosis, cell death, and breast cancer. Aromatase Inhibitors and Their Application to the Treatment of Breast Cancer. Aromatase Inhibition In Breast Cancer: Update of Clinical Applications. Testosterone and another androgens in breast cancer: Clinical Implications. Combination of breast cancer prevention with tissue-targeted hormone replacement therapy. Practical progress in the chemoprevention of breast cancer with selective estrogen receptor modulators (SERMs). Oncostatic effect of analogs of LHRH on breast cancer. Vitamin D and Breast Cancer. Insulin-like Growth Factor Signaling in Normal Mammary Gland Development and Breast Cancer Progression. Insulin-like Growth Factor-I and Breast Cancer: Epidemiological and Clinical Data. Proliferation of breast cells by steroid hormones and their metabolites. Lignans and Breast Cancer. Breast Cancer Risk, Soyfood Intake and Isoflavone Exposure: A Review of the In Vitro, Animal, Epidemiologic, and Clinical Literature. Body Size and Breast Cancer. Antiangiogenic therapy of breast cancer: Rationale and clinical results. Cytotoxic Therapy and Other Non-Hormonal Approaches for the Treatment of Metastatic Breast Cancer. Adjuvant and Neoadjuvant Systemic Chemotherapy for Operable and Locally Advanced Breast Cancer. BRCA1, BRCA2, and Hereditary Breast Cancer.